STAT3 and pancreatic neoplasm: This has also been demonstrated with LysM-Cre–mediated STAT3 deletion which reduced tumor growth in pancreatic tumor models [104] and improved T cell-mediated anti-tumor responses observed in models of lung [106] and colorectal tumors [107].